Keeley-Teton Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Keeley-Teton Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$218K	Hold	3,570	–	–	0.03%	353
2024 Q4	$202K	Sell	3,570 -1,500	-30%	-$83.8K	0.02%	363
2024 Q3	$262K	Buy	+5,070	New	+$238K	0.03%	359
2024 Q1	–	Sell	-3,927	Closed	-$201K	–	349
2023 Q4	$201K	Hold	3,927	–	–	0.03%	342
2023 Q3	$228K	Sell	3,927 -600	-13%	-$36.8K	0.03%	330
2023 Q2	$290K	Hold	4,527	–	–	0.04%	320
2023 Q1	$314K	Buy	4,527 +600	+15%	+$42.3K	0.04%	332
2022 Q4	$283K	Sell	3,927 -491	-11%	-$37K	0.04%	341
2022 Q3	$314K	Buy	4,418 +491	+13%	+$35.6K	0.04%	321
2022 Q2	$302K	Sell	3,927 -305	-7%	-$23.2K	0.04%	336
2022 Q1	$309K	Hold	4,232	–	–	0.03%	348
2021 Q4	$264K	Buy	+4,232	New	+$248K	0.03%	301
2021 Q2	–	Sell	-4,232	Closed	-$267K	–	276
2021 Q1	$267K	Hold	4,232	–	–	0.03%	295
2020 Q4	$263K	Buy	4,232 +2	+0%	+$123	0.04%	238
2020 Q3	$255K	Buy	4,230 +3	+0.1%	+$181	0.04%	226
2020 Q2	$249K	Buy	4,227 +2	+0%	+$120	0.04%	224
2020 Q1	$236K	Buy	4,225 +2	+0%	+$122	0.04%	227
2019 Q4	$271K	Buy	4,223 +2	+0%	+$115	0.03%	240
2019 Q3	$214K	Buy	+4,221	New	+$198K	0.02%	254

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Keeley-Teton Advisors's BMY Position: Q1 2025 in Review

Keeley-Teton Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2025 at 3,570 shares worth $218K. The position accounts for 0.03% of the portfolio, ranked #353.

Keeley-Teton Advisors first reported a position in BMY in Q3 2019 and has held it in 19 quarters since. The position peaked at $314K in Q3 2022. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Keeley-Teton Advisors held 3,570 shares of Bristol-Myers Squibb worth $218K as of Q1 2025.
Keeley-Teton Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2025.
Bristol-Myers Squibb made up 0.03% of Keeley-Teton Advisors's portfolio in Q1 2025, its #353 holding.
Keeley-Teton Advisors first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 19 quarters since.
Keeley-Teton Advisors's Bristol-Myers Squibb position peaked at $314K in Q3 2022.
2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Keeley-Teton Advisors's 13F filing for Q1 2025, filed 14 May 2025.